Created at 10:03 a.m. Sep, 05, 2025
Author: erinelisepeterson
Related Note: 1487117300306 3
Rationale for change

Cytotoxic T cells (CTLs) can kill target cells through two main mechanisms:

Perforin/Granzyme pathway – perforin forms pores and granzymes enter to trigger apoptosis.

Death receptor pathway – Fas ligand (FasL) on the CTL binds Fas (CD95) on the target cell, activating caspases and apoptosis.

👉 The Fas–FasL pathway does not cause TNF release. Instead, it directly activates apoptotic signaling in the target cell.

Where TNF (tumor necrosis factor, often TNF-α) comes in:

CTLs (and NK cells, and activated macrophages) can secrete TNF-α as part of their effector function.

TNF-α can bind TNFR1 on target cells, which may trigger apoptosis (through caspase-8) or promote survival/inflammation (through NF-κB), depending on the signaling context.

TNF is released by the immune effector cell, not by the dying target cell.

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#FirstAid::02_Immunology::02_Cellular_Components::07_Differentiation_of_T_cells::*Cytotoxic_T_Cells #AK_Step1_v12::#B&B::18_Pathology::01_General::04_Apoptosis::Extra #AK_Step1_v12::#Pixorize::02_Immunology::04_B_Cells_&_T_Cells::10_Cytotoxic_(Killer)_T_Cells #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::07_Apoptotic_Pathways #AK_Step1_v12::#Pathoma::02_Inflammation::02_Chronic_Inflammation #AK_Step1_v12::#UWorld::Step::298 #AK_Step1_v12::#OME_banner::Basic_Science::06_Inflammation_and_Neoplasia::03_Apoptosis #AK_Step1_v12::#AMBOSS::6MajpO #AK_Step1_v12::#OME::PreClinical::General_Pathology::Pathology:_Inflammation_&_Neoplasia::Apoptosis #AK_Step1_v12::#Bootcamp::Immunology::05_T-cells::03_T-cell_Activation #AK_Step1_v12::#AMBOSS::URabm4 #AK_Step1_v12::#NinjaNerd::02_Immunology::01_Physiology::08_T-Cell_Development #AK_Step1_v12::#Physeo::08_Immunology::01_Immunology::11_Positive_&_Negative_Selection #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Immunology_+_General_Pathology::Immunology #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::07_Apoptotic_Pathways #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::02_Anatomy::14_T_cells::*Cytotoxic #AK_Step1_v12::#SketchyImmunology::03_The_Adaptive_Immune_System::02_Cell_Mediated_Immunity_(T-Cells)::05_Cytotoxic_T-cells #AK_Step1_v12::#Physeo::08_Immunology::01_Immunology::10_NK_Cells_&_Cytotoxic_T_Cells #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::^Systems::Immunology::CellMediated #AK_Step1_v12::#UWorld::COMLEX::23411 #AK_Step1_v12::#B&B::13_Immunology::01_Basic_Immunology::02_T-cells #AK_Step1_v12::#FirstAid::02_Immunology::02_Cellular_Components::09_Cytotoxic_T_cells